annual EBITDA:
$6.89B-$198.91M(-2.81%)Summary
- As of today (May 21, 2025), IX annual EBITDA is $6.89 billion, with the most recent change of -$198.91 million (-2.81%) on March 1, 2025.
- During the last 3 years, IX annual EBITDA has fallen by -$1.11 billion (-13.90%).
- IX annual EBITDA is now -13.90% below its all-time high of $8.00 billion, reached on March 31, 2022.
Performance
IX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
N/ASummary
- IX quarterly EBITDA is not available.
Performance
IX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM EBITDA:
N/ASummary
- IX TTM EBITDA is not available.
Performance
IX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IX EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -2.8% | - | - |
3 y3 years | -13.9% | - | - |
5 y5 years | -8.3% | - | - |
IX EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -13.9% | +8.1% | ||||
5 y | 5-year | -13.9% | +8.1% | ||||
alltime | all time | -13.9% | +261.3% |
IX EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | $6.89B(-2.8%) | - | - |
Mar 2024 | $7.09B(+11.3%) | $2.08B(+16.4%) | $7.06B(+3.6%) |
Dec 2023 | - | $1.79B(+11.7%) | $6.82B(+0.8%) |
Sep 2023 | - | $1.60B(+0.9%) | $6.76B(+3.9%) |
Jun 2023 | - | $1.59B(-13.6%) | $6.51B(+2.3%) |
Mar 2023 | $6.37B(-20.4%) | $1.84B(+5.9%) | $6.36B(-9.4%) |
Dec 2022 | - | $1.73B(+28.7%) | $7.02B(+0.9%) |
Sep 2022 | - | $1.35B(-6.5%) | $6.96B(-8.5%) |
Jun 2022 | - | $1.44B(-42.2%) | $7.60B(-4.7%) |
Mar 2022 | $8.00B(+24.4%) | $2.49B(+49.2%) | $7.97B(+12.3%) |
Dec 2021 | - | $1.67B(-16.1%) | $7.10B(-0.4%) |
Sep 2021 | - | $1.99B(+9.8%) | $7.13B(+6.5%) |
Jun 2021 | - | $1.81B(+11.9%) | $6.69B(+4.1%) |
Mar 2021 | $6.43B(-14.4%) | $1.62B(-4.4%) | $6.43B(+1.3%) |
Dec 2020 | - | $1.70B(+9.1%) | $6.35B(-4.5%) |
Sep 2020 | - | $1.56B(+0.1%) | $6.65B(-8.3%) |
Jun 2020 | - | $1.55B(+0.8%) | $7.25B(-3.4%) |
Mar 2020 | $7.51B(+6.1%) | $1.54B(-22.9%) | $7.51B(-4.3%) |
Dec 2019 | - | $2.00B(-7.3%) | $7.85B(+6.3%) |
Sep 2019 | - | $2.16B(+19.1%) | $7.38B(+4.8%) |
Jun 2019 | - | $1.81B(-3.7%) | $7.04B(-0.6%) |
Mar 2019 | $7.08B(-1.0%) | $1.88B(+22.7%) | $7.08B(+4.0%) |
Dec 2018 | - | $1.53B(-15.6%) | $6.81B(-2.6%) |
Sep 2018 | - | $1.82B(-1.8%) | $6.99B(-0.2%) |
Jun 2018 | - | $1.85B(+15.1%) | $7.01B(-1.9%) |
Mar 2018 | $7.15B(+2.9%) | $1.61B(-6.1%) | $7.14B(+0.3%) |
Dec 2017 | - | $1.71B(-6.6%) | $7.12B(-0.2%) |
Sep 2017 | - | $1.83B(-7.7%) | $7.14B(+0.6%) |
Jun 2017 | - | $1.99B(+25.0%) | $7.10B(+2.1%) |
Mar 2017 | $6.95B(+17.6%) | $1.59B(-8.0%) | $6.95B(+5.9%) |
Dec 2016 | - | $1.73B(-3.6%) | $6.57B(+6.2%) |
Sep 2016 | - | $1.79B(-2.6%) | $6.18B(+1.9%) |
Jun 2016 | - | $1.84B(+53.0%) | $6.07B(+3.0%) |
Mar 2016 | $5.91B(-0.0%) | $1.20B(-10.5%) | $5.89B(-1.9%) |
Dec 2015 | - | $1.34B(-20.0%) | $6.00B(+1.6%) |
Sep 2015 | - | $1.68B(+1.0%) | $5.91B(+0.8%) |
Jun 2015 | - | $1.66B(+26.3%) | $5.86B(-1.4%) |
Mar 2015 | $5.91B(+2.8%) | $1.32B(+5.2%) | $5.94B(-7.2%) |
Dec 2014 | - | $1.25B(-23.3%) | $6.40B(-0.6%) |
Sep 2014 | - | $1.63B(-6.4%) | $6.44B(+5.0%) |
Jun 2014 | - | $1.74B(-2.0%) | $6.14B(+7.0%) |
Mar 2014 | $5.75B | $1.78B(+38.0%) | $5.74B(+11.4%) |
Dec 2013 | - | $1.29B(-2.8%) | $5.15B(-2.3%) |
Sep 2013 | - | $1.33B(-1.3%) | $5.28B(-1.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2013 | - | $1.34B(+12.6%) | $5.35B(-2.1%) |
Mar 2013 | $5.46B(+7.2%) | $1.19B(-15.5%) | $5.47B(+0.8%) |
Dec 2012 | - | $1.41B(+0.6%) | $5.42B(+3.7%) |
Sep 2012 | - | $1.40B(-3.8%) | $5.23B(+0.2%) |
Jun 2012 | - | $1.46B(+27.1%) | $5.22B(+2.6%) |
Mar 2012 | $5.09B(+16.7%) | $1.15B(-5.8%) | $5.09B(+5.0%) |
Dec 2011 | - | $1.22B(-12.5%) | $4.84B(-0.4%) |
Sep 2011 | - | $1.39B(+4.9%) | $4.87B(+4.8%) |
Jun 2011 | - | $1.33B(+46.9%) | $4.64B(+6.3%) |
Mar 2011 | $4.36B(+33.1%) | $904.03M(-27.0%) | $4.37B(+2.3%) |
Dec 2010 | - | $1.24B(+5.8%) | $4.27B(+9.3%) |
Sep 2010 | - | $1.17B(+11.1%) | $3.91B(+12.5%) |
Jun 2010 | - | $1.05B(+30.8%) | $3.47B(+5.7%) |
Mar 2010 | $3.28B(+8.4%) | $806.81M(-7.7%) | $3.28B(+6.0%) |
Dec 2009 | - | $874.55M(+18.7%) | $3.10B(+28.6%) |
Sep 2009 | - | $736.51M(-15.0%) | $2.41B(-9.4%) |
Jun 2009 | - | $866.90M(+39.8%) | $2.66B(-10.2%) |
Mar 2009 | $3.02B(-33.6%) | $620.22M(+234.3%) | $2.96B(-20.3%) |
Dec 2008 | - | $185.55M(-81.2%) | $3.72B(-18.6%) |
Sep 2008 | - | $987.11M(-15.5%) | $4.56B(-1.8%) |
Jun 2008 | - | $1.17B(-15.0%) | $4.65B(+1.2%) |
Mar 2008 | $4.55B(-2.5%) | $1.38B(+33.1%) | $4.59B(+5.7%) |
Dec 2007 | - | $1.03B(-3.3%) | $4.34B(-5.9%) |
Sep 2007 | - | $1.07B(-4.0%) | $4.62B(-0.3%) |
Jun 2007 | - | $1.11B(-1.4%) | $4.63B(+9.2%) |
Mar 2007 | $4.67B(+17.5%) | $1.13B(-13.5%) | $4.24B(+1.5%) |
Dec 2006 | - | $1.31B(+20.6%) | $4.18B(+10.3%) |
Sep 2006 | - | $1.08B(+49.7%) | $3.78B(+1.2%) |
Jun 2006 | - | $723.09M(-32.1%) | $3.74B(-6.2%) |
Mar 2006 | $3.97B(+25.5%) | $1.06B(+16.5%) | $3.99B(+5.8%) |
Dec 2005 | - | $913.89M(-11.8%) | $3.77B(+1.6%) |
Sep 2005 | - | $1.04B(+6.6%) | $3.71B(+8.8%) |
Jun 2005 | - | $971.66M(+14.8%) | $3.41B(+7.0%) |
Mar 2005 | $3.16B(+25.8%) | $846.65M(-0.9%) | $3.19B(+36.2%) |
Dec 2004 | - | $854.14M(+15.9%) | $2.34B(+57.5%) |
Sep 2004 | - | $736.90M(-1.5%) | $1.48B(+98.5%) |
Jun 2004 | - | $747.82M | $747.82M |
Mar 2004 | $2.52B(+32.0%) | - | - |
Mar 2003 | $1.91B(-14.9%) | - | - |
Mar 2002 | $2.24B(-10.8%) | - | - |
Mar 2001 | $2.51B(+10.5%) | - | - |
Mar 2000 | $2.27B(+13.6%) | - | - |
Mar 1999 | $2.00B(-8.0%) | - | - |
Mar 1998 | $2.17B | - | - |
FAQ
- What is ORIX annual EBITDA?
- What is the all time high annual EBITDA for ORIX?
- What is ORIX annual EBITDA year-on-year change?
- What is the all time high quarterly EBITDA for ORIX?
- What is the all time high TTM EBITDA for ORIX?
What is ORIX annual EBITDA?
The current annual EBITDA of IX is $6.89B
What is the all time high annual EBITDA for ORIX?
ORIX all-time high annual EBITDA is $8.00B
What is ORIX annual EBITDA year-on-year change?
Over the past year, IX annual EBITDA has changed by -$198.91M (-2.81%)
What is the all time high quarterly EBITDA for ORIX?
ORIX all-time high quarterly EBITDA is $2.49B
What is the all time high TTM EBITDA for ORIX?
ORIX all-time high TTM EBITDA is $7.97B